Fundraising to last Aradigm to product launch in 2007
This article was originally published in Clinica
Executive Summary
Aradigm has arranged a $12.5m private placement that it believes will provide enough funds until the launch of its first noninvasive drug delivery product. The proceeds will be used for R&D, working capital and general operations.